Date
Time
Place
Tuesday 19th February 2013
8.00am – 9.30am
Seminar room 1 & 2, Level 3
Monash Institute of Medical Research (MIMR)
29-31 Wright St Clayton (Please enter via MIMR’s
main entrance on Wright St).
RSVP
info@mccc.edu.au
Clinical Developments in Targeted Therapies
Guest Speaker: Professor Charles Swanton, Translational Cancer Research Laboratories,
UK Research Institute, University College, London
Charles completed his PhD in 1998 at the Imperial Cancer Research Fund Laboratories on the UCL MBPhD programme before
completing his medical oncology and CR-UK funded post-doctoral clinician scientist training in 2008. Charles was appointed
Medical Research Council and Cancer Research UK senior clinical research fellow and Group Leader of the Translational
Cancer Therapeutics laboratory at the CR-UK London Research Institute in 2008 focusing on personalised cancer medicine
through an understanding of mechanisms of drug resistance, intratumour heterogeneity and genomic instability. He combines
his laboratory research with clinical duties focused on drug development in lung and breast cancer.
Speaker Program
8.00am Dr Vinod Ganju, Director, Medical Oncologist, Monash Cancer Care
Welcome and Introduction
8.15am Prof Charles Swanton, Translational Cancer Research Laboratories, UK
Research Institute, University College, London
Targeted Therapies
8.55am Prof Neil Watkins, Centre for Cancer Research, Monash Institute of
Medical Research
Modelling of Chemotherapy Resistance
9.10am Q & A Discussion